Flemming Ørnskov
Flemming Ørnskov | |
|---|---|
| Nationality | Danish |
| Alma mater | University of Copenhagen INSEAD Harvard University |
| Occupation(s) | CEO, Shire plc |
Flemming Ørnskov is a Danish businessman, who has been the chief executive officer (CEO) of Shire plc, a FTSE 100 speciality biopharmaceutical company, since 30 April 2013, succeeding Angus Russell.[2] He previously worked for Bayer.
Ornskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[1]
References
- ^ a b "Executive Profile* Flemming Ornskov M.D., MBA, MPH". Bloomberg. Retrieved 5 August 2015.
- ^ "Shire chief finds right prescription for growth". The Telegraph. Retrieved 20 March 2014.
  | This Danish biographical article is a stub. You can help Wikipedia by expanding it. |
 | This business-related biographical article is a stub. You can help Wikipedia by expanding it. |